Results 101 to 110 of about 1,950 (155)

Roxadustat for the treatment of anemia in patients with chronic kidney disease: a Meta-analysis

, 2019
Objective Our study aimed to evaluate the efficacy and safety of roxadustat for the treatment of renal anemia in patients with chronic kidney disease(CKD) by meta-analysis.Methods PubMed, Embase, Cochrane Library, Web of Science, Chinese Biomedical ...
HU Shuang, WANG Rui, HE Hong, HU Hong-tao, SHUI Hua   +4 more
core  

Physiological Hypoxia and Pharmacological HIF Stabilization Induce Distinct but Overlapping Responses in Retinal Pigment Epithelial Cells. [PDF]

Pharmaceuticals (Basel)
Gáll T, Pethő D, Póliska S, Balla J, Balla G.   +4 more
europepmc   +1 more source

Impaired liver-muscle lactate metabolism causes sarcopenia via lactic acidosis in skeletal muscle in mice. [PDF]

Sci Adv
Eguchi T, Hayashiji N, Tabata S, Kabetani K, Shintani Y, Makinoshima H, Ito N.   +6 more
europepmc   +1 more source

Effects of hypoxia-inducible factor prolyl hydroxylase inhibitors on transfusion and intravenous iron use in chronic kidney disease anemia: a systematic review and meta-analysis. [PDF]

Front Pharmacol
Huang J, Wang Y, Zhang H, Wang A, Zhang M, Cao Y.   +5 more
europepmc   +1 more source

HIF1 Stabilization by Roxadustat Improves Cognition and Prevents Neuron Loss in Alzheimer's Diseases In Vivo. [PDF]

Biology (Basel)
Mitroshina EV, Strelkova PL, Korokozova MV, Vedunova MV.   +3 more
europepmc   +1 more source

Efecto de Roxadustat en modelos de enfermedad de Alzheimer

La enfermedad de Alzheimer (EA) es el trastorno neurodegenerativo más prevalente en la actualidad, cursando con un declive cognitivo y conductual progresivo.
Capelo Carrasco, Nicolás
core  

Roxadustat in lupus nephritis: a novel therapeutic signal for multifactorial anaemia. [PDF]

Lupus Sci Med
Martín-Portugués M, Moreno-Torres V, Durán-Del Campo P, Martín-Tesillano L, Portoles J, Huerta A.   +5 more
europepmc   +1 more source

Roxadustat for CKD-related anemia in patients undergoing peritoneal dialysis: a systematic review and meta-analysis. [PDF]

BMC Nephrol
Elkoumi O, Elkoumi A, Elbairy MK, Mahmoud MAT, Irfan H.   +4 more
europepmc   +1 more source

Clinically approved HIF-PHIs modulate redox metabolism, cell growth, and angiogenesis independent of HIF-1α/HIF-2α. [PDF]

Redox Biol
Mennerich D, Khoder-Agha F, Beter M, Dimova EY, Ylä-Herttuala S, Kietzmann T.   +5 more
europepmc   +1 more source

Association of nutritional indices with hyporesponsiveness to hypoxia-inducible factor-prolyl hydroxylase inhibitors in patients with chronic kidney disease: a single-center retrospective observational study. [PDF]

BMC Nephrol
Minamishima T, Mizoguchi H, Nishibori N, Ikesue H.   +3 more
europepmc   +1 more source